Table 2. Classification of Myocarditis Cases Reported to the Ministry of Health.*.
Timing of Myocarditis Diagnosis | Brighton Collaboration Classification of Myocarditis | |||||
---|---|---|---|---|---|---|
Level 1 | Level 2 | Level 3 | Level 4 | Level 5 | All Levels | |
number of cases | ||||||
All cases | 118 | 153 | 3 | 9 | 21 | 304 |
Vaccinated persons | ||||||
≤21 days after first dose and 30 days after second dose | 55 | 81 | 1 | 5 | 9 | 151 |
>21 days after first dose and 30 days after second dose | 15 | 23 | 0 | 2 | 5 | 45 |
Unvaccinated persons | 48 | 49 | 2 | 2 | 7 | 108 |
In the Brighton Collaboration classification system for the diagnosis of myocarditis, level 1 indicates definite, level 2 probable, level 3 possible, level 4 insufficient data, and level 5 ruled out. Included are data for persons who had a delayed second dose of vaccine and who received a diagnosis of myocarditis 22 days or longer after the first dose and those in whom myocarditis developed more than 30 days after the second dose, so the diagnosis was not considered to have been made in temporal proximity to vaccination.